VIA
STJ

Vident Investment Advisory’s St Jude Medical STJ Stock Holding History

Vident Investment Advisory’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-4,433
Closed -$355K – 513
2016
Q4 		$355K Sell
4,433
-1,835
-29% -$146K 0.04% 352
2016
Q3 		$500K Buy
+6,268
New +$506K 0.07% 346
2015
Q4 		– Sell
-8,577
Closed -$541K – 1026
2015
Q3 		$541K Buy
8,577
+8,125
+1,798% +$580K 0.08% 485
2015
Q2 		$33K Buy
+452
New +$32.7K ﹤0.01% 821
2015
Q1 		– Sell
-5,704
Closed -$371K – 822
2014
Q4 		$371K Buy
+5,704
New +$367K 0.13% 381

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Vident Investment Advisory's STJ Position: Q1 2017 in Review

Vident Investment Advisory sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 4,433 shares — an estimated $355K sold.

Vident Investment Advisory first reported a position in STJ in Q4 2014 and held it in 5 quarters. The position peaked at $541K in Q3 2015. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Vident Investment Advisory reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Vident Investment Advisory sold 4,433 St Jude Medical shares in Q1 2017, an estimated $355K.
  • Vident Investment Advisory first reported a position in St Jude Medical in Q4 2014 and held it in 5 quarters.
  • Vident Investment Advisory's St Jude Medical position peaked at $541K in Q3 2015.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Vident Investment Advisory's 13F filing for Q1 2017, filed 10 May 2017.